3
Views
0
CrossRef citations to date
0
Altmetric
Cardiovascular Agents (Including Blood Products)

Patent Evaluation: TGF-β as a potential antihypertensive agent

Pages 185-186 | Published online: 02 Mar 2011
 

Summary

Novelty: Novel methods for the modulation of blood pressure, using transforming growth factor-β (TGF-β) and TGF-β antagonists are disclosed. The TGFs are potentially useful as antihypertensive agents.

Biology: In vivo cynomolgous monkey studies are described. Blood pressure is monitored via arterial catheratization. Recombinant mature TGF-β1, isolated and transferred from Chinese hamster ovary cells, induces significant and sustained decreases in BP on injection of rTGF-β1 in doses of 0.51 mg/kg. No significant fluctuation in BP is observed in the control.

Chemistry: Transforming growth factors may be obtained from natural sources. They can also be produced via conventional recombinant DNA or chemical techniques. Preparative references are presented.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.